Furthermore, the p-AMPK activity of colitis LP CD4+ T cells was significantly suppressed by combination AICAR and C.C. treatment in comparison to AICAR and increased in comparison to C.C. (Fig. 3D,E). Here, CD4 is linked to colitis.